Chemours expands ion exchange materials
Chemours is to invest $200 million to increase capacity and advance technology for its Nafion brand ion exchange materials at the site in Villers-Saint-Paul, France. The investment is subject to obtaining the necessary permits and licences for construction and operations. It includes ionomers and associated membranes.
Mark Newman, president and CEO, commented: “Chemours has chosen France for this investment in the hydrogen economy because of the strong alignment between our sustainable growth vision, the French government’s goal to create a reliable and strong hydrogen economy and the EU’s ambition to deliver a clean energy transition based on the objectives set in the EU Climate Law.”
RELATED ARTICLES
The US Environmental Protection Agency (EPA) has taken two separate actions on per- and polyfluorinated substances (PFAS), both being part of its PFAS strategic roadmap, which aims to implement legislation by Q4 to reduce and destroy PFAS contamination in water, air and soil.
The first joint Europe-wide assessment of the drivers and impact of chemical pollution by the European Environment Agency (EEA) and the European Chemicals Agency (ECHA) has concluded that, despite progress in some areas, “more work is still needed to reduce the impact of harmful substances on hum
Lubrizol has opened a new Global Capability Centre (GCC) in Pune, India, as “a strategic hub to accelerate its growth in the region and enable closer collaboration for its customers and employees”.
International Process Plants (IPP), which buys and sells industrial plants and equipment, has acquired Henkel’s detergent plant in Lomazzo, Italy, in partnership with Maynards, a specialist in industrial liquidation auction services.
Chemours has completed its planned procedures with respect to an internal review that it first announced on 29 February. This essentially confirmed the details revealed in an interim report on 7 March.
Symrise and India’s Virchow Group have agreed to make personal care ingredients from the Symrise portfolio through a new joint venture called Vizag Care Ingredients, beginning within 1H. This will be based on Virchow’s synthetic chemistry capabilities for API manufacture.
